OVA (329-337) is widely used in immunological research as a model antigen, particularly in studies involving T-cell activation and immune response mechanisms. It serves as a well-characterized epitope recognized by specific T-cell receptors, making it ideal for investigating antigen presentation pathways, especially in the context of MHC class I molecules. This peptide is frequently employed in experiments using OT-I transgenic mice, where it helps assess cytotoxic T lymphocyte (CTL) responses, immune tolerance, and vaccine efficacy. Due to its defined immunogenic properties, OVA (329-337) is also utilized in the development and testing of adjuvants, immunotherapies, and delivery systems such as nanoparticles and dendritic cell-based vaccines. Its consistent behavior across experimental models makes it a standard tool in both basic and applied immunology.